- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
Clear All
51 Viral Infections Trials Near You
Power is an online platform that helps thousands of Viral Infections patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerBK CTL for Viral Infections
Trial Details
Key Eligibility Criteria
40 Participants Needed
T-cell Therapy for Viral Infections
Trial Details
Key Eligibility Criteria
750 Participants Needed
Tozorakimab for Viral Pneumonia
Trial Details
Key Eligibility Criteria
2870 Participants Needed
AV-001 for COVID-19
Trial Details
Key Eligibility Criteria
120 Participants Needed
Ibuzatrelvir for Coronavirus
Trial Details
Key Eligibility Criteria
2330 Participants Needed
VST Therapy for Post-Transplant Viral Infections
Trial Details
Key Eligibility Criteria
42 Participants Needed
VST Infusion for Post-Transplant Viral Infections
Trial Details
Key Eligibility Criteria
750 Participants Needed
Viral Specific T-cells for Post-Transplant Viral Infections
Trial Details
Key Eligibility Criteria
180 Participants Needed
HIV Vaccine for HIV/AIDS
Trial Details
Key Eligibility Criteria
36 Participants Needed
Far-UVC Light for Respiratory Infections
Trial Details
Key Eligibility Criteria
500 Participants Needed
mRNA Vaccine for Cytomegalovirus (CMV)
Trial Details
Key Eligibility Criteria
291 Participants Needed
HIV Trimer mRNA Vaccines for HIV Prevention
Trial Details
Key Eligibility Criteria
108 Participants Needed
Case Management for HIV
Trial Details
Key Eligibility Criteria
180 Participants Needed
mHealth App for HIV with Substance Use Disorder
Trial Details
Key Eligibility Criteria
806 Participants Needed
NST Therapy for Chronic Norovirus in Immunocompromised Patients
Trial Details
Key Eligibility Criteria
48 Participants Needed
Bevacizumab for Respiratory Warts
Trial Details
Key Eligibility Criteria
50 Participants Needed
FluMos-v2 Vaccine for Flu
Trial Details
Key Eligibility Criteria
45 Participants Needed
Medical Herbs for COVID-19
Trial Details
Key Eligibility Criteria
100 Participants Needed
Adoptive Immunotherapy for Viral Infections
Trial Details
Key Eligibility Criteria
36 Participants Needed
VST Therapy for Viral Infections
Trial Details
Key Eligibility Criteria
31 Participants Needed
Why Other Patients Applied
"I have dealt with voice and vocal fold issues related to paralysis for over 12 years. This problem has negatively impacted virtually every facet of my life. I am an otherwise healthy 48 year old married father of 3 living. My youngest daughter is 12 and has never heard my real voice. I am now having breathing issues related to the paralysis as well as trouble swallowing some liquids. In my research I have seen some recent trials focused on helping people like me."
"I've been struggling with ADHD and anxiety since I was 9 years old. I'm currently 30. I really don't like how numb the medications make me feel. And especially now, that I've lost my grandma and my aunt 8 days apart, my anxiety has been even worse. So I'm trying to find something new."
"My orthopedist recommended a half replacement of my right knee. I have had both hips replaced. Currently have arthritis in knee, shoulder, and thumb. I want to avoid surgery, and I'm open-minded about trying a trial before using surgery as a last resort."
"I changed my diet in 2020 and I’ve lost 95 pounds from my highest weight (283). I am 5’3”, female, and now 188. I still have a 33 BMI. I've been doing research on alternative approaches to continue my progress, which brought me here to consider clinical trials."
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
VST Therapy for Post-Transplant Viral Infections
Trial Details
Key Eligibility Criteria
32 Participants Needed
Omalizumab for Childhood Asthma
Trial Details
Key Eligibility Criteria
300 Participants Needed
Decision Support for Lower Respiratory Infections in Children
Trial Details
2800 Participants Needed
Point-of-Care Tests for HIV Diagnosis
Trial Details
Key Eligibility Criteria
408 Participants Needed
SAVVY Intervention for HIV
Trial Details
Key Eligibility Criteria
288 Participants Needed
H3N2 Virus Challenge for Flu
Trial Details
Key Eligibility Criteria
33 Participants Needed
Integrated Strategy for PrEP Uptake in HIV Prevention
Trial Details
Key Eligibility Criteria
4800 Participants Needed
HydroVax-001B Vaccine for West Nile Virus
Trial Details
Key Eligibility Criteria
30 Participants Needed
JYNNEOS Vaccine for Viral Diseases
Trial Details
Key Eligibility Criteria
20 Participants Needed
Xofluza for Flu
Trial Details
Key Eligibility Criteria
540 Participants Needed
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Frequently Asked Questions
How much do Viral Infections clinical trials pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do Viral Infections clinical trials work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Viral Infections trials 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length for Viral Infections is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a Viral Infections medical study?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest Viral Infections clinical trials?
Most recently, we added FluMos-v2 Vaccine for Flu, HydroVax-001B Vaccine for West Nile Virus and Communication Strategies for Increasing HPV Vaccination to the Power online platform.